Latest filing published 21 Jan 2022 for Guard Therapeutics International AB (publ), €155k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Tobias Larsson Agervald: trading record in brief
Filings by Tobias Larsson Agervald span 2 companies, the busiest being Guard Therapeutics International AB (publ) and Guard Therapeutics AB. In total, 4 filings cover trades dated from 12 February 2019 to 20 January 2022.
The open-market side counts 2 purchases for €193k alongside 1 sale for €155k. Taken together, the purchases exceed the sales by €38k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. In 2022 alone, the filings show 1 purchase and 1 sale.
On 21 January 2022 came the latest disclosure, an open-market purchase for €155k in Guard Therapeutics International AB (publ). Typically, a trade is published a median of 1 day after it takes place. For comparison, MAR article 19 gives managers three business days to notify a trade. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Tobias Larsson Agervald
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,252,640 shares@ SEK 1.2879.3% of flowAktieISIN SE0009973357FI:csv-48e2de2bf2dffed48fd6
- 214,284 shares@ SEK 1.4015.0% of flowAktieISIN SE0009973357FI:csv-f613ff116db1fa222cc4
- 2,105,263 shares@ SEK 0.19100.0% of flowSyntetisk optionISIN SE0009973357FI:csv-488fe8d0bc02998051ceCanonical exit: 13 May 2019 (T+90)
3 of 3 declarations